Template:Weakness DDX: Difference between revisions

 
(One intermediate revision by one other user not shown)
Line 5: Line 5:
*** [[Hemorrhagic stroke]]
*** [[Hemorrhagic stroke]]
*** [[Multiple sclerosis]]
*** [[Multiple sclerosis]]
*** [[Amyotrophic Lateral Sclerosis (ALS)]] (UMN & LMN)
*** [[Amyotrophic Lateral Sclerosis (ALS)]] (upper and lower motor neuron)
**Lower motor neuron:
**Lower motor neuron:
*** Spinal and bulbar muscular atrophy (Kennedy's syndrome)
*** Spinal and bulbar muscular atrophy (Kennedy's syndrome)
Line 21: Line 21:
*** [[Tick paralysis]]
*** [[Tick paralysis]]
*** [[Diabetic peripheral neuropathy]]
*** [[Diabetic peripheral neuropathy]]
**NMJ disease:
**Neuromuscular junction disease:
*** [[Myasthenia gravis]] crisis
*** [[Myasthenia gravis]] crisis
*** [[Botulism]]
*** [[Botulism]]
Line 47: Line 47:
*** Polypharmacy
*** Polypharmacy
*** Malignancy
*** Malignancy
*** Aortic disease - occlusion, stenosis, dissection
**Other causes of weakness and paralysis
**Other causes of weakness and paralysis
***[[Acute intermittent porphyria]] (ascending weakness)
***[[Acute intermittent porphyria]] (ascending weakness)

Latest revision as of 14:01, 17 June 2023

Weakness